
Built for the nextgeneration ofautoimmune therapeutics.
Vie Ventures is a specialist biotechnology investment firm focused on autoimmune and immune-mediated therapeutics. We combine market-rate venture investing, embedded immunology expertise, and disease-focused relationships to help promising therapies advance toward clinical proof of concept.
Our approach
Vie invests primarily in advanced-preclinical through Phase 2 therapeutic opportunities, with selective company creation, seed and other investments. We evaluate mechanisms across diseases, invest around meaningful development milestones, and seek to lead or co-lead financings where appropriate, with capital reserved for follow-on support. Strategic Collaborators provide disease insight and patient perspective; Vie retains investment responsibility and allocation discretion.
Shared immune biology
Related immune pathways can connect therapeutic opportunities across diseases.
Multi-indication potential
Evidence in one disease may inform development in others, with each indication evaluated on its own merits.
Specialist investment execution
Scientific underwriting, financing discipline and development milestones guide investment decisions.
Disease-community insight
Independent Strategic Collaborators contribute disease expertise and patient perspective.
The Vie model
From scientific insight to therapeutic progress.
Specialist biotechnology investing
Scientific underwriting, venture experience and financing discipline.
Disease-community insight
Independent disease expertise, patient perspective and scientific relationships.
Vie Ventures
Investment judgment and execution.
Evaluate the
science
Assess therapeutic mechanisms across diseases, evaluating each opportunity on its own merits.
Invest with discipline
Invest around meaningful development milestones, with capital reserved for follow-on support.
Support development
Help promising therapies advance toward clinical proof of concept.
Advancing the next generation of autoimmune therapeutics.
Vie Impact
Learn how biotech leaders and families can participate in Vie’s cross-autoimmune strategy and help build future philanthropic capacity.
Explore Vie ImpactStrategic collaborators
How our network of disease-focused ecosystems makes us a value-added partner for companies and co-investors.
Learn more about our strategic collaboratorsBuilding the future of autoimmune therapeutics.
Whether you are a prospective investor, a strategic collaborator, or a company creating next-generation therapies, we would be glad to connect.
Or email us directly at contact@vieventures.com.

